Phathom Pharmaceuticals, Inc.
PHAT
$4.41
$0.194.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.06% | 56.63% | 11.01% | 148.68% | 145.45% |
| Total Receivables | 2,270.01% | -- | -- | -- | -- |
| Inventory | 165.56% | 2,702.70% | 1,861.26% | -- | -- |
| Prepaid Expenses | 58.15% | 15.78% | 76.91% | 24.14% | 157.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.38% | 64.88% | 18.26% | 143.35% | 147.60% |
|
|
|||||
| Total Current Assets | -9.38% | 64.88% | 18.26% | 143.35% | 147.60% |
| Net Property, Plant & Equipment | -42.31% | -31.98% | -5.95% | -4.07% | 3.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 25.85% | 62.45% | 174.14% | 1,511.82% | 1,490.67% |
| Total Assets | -8.58% | 63.32% | 20.50% | 147.55% | 151.10% |
|
|
|||||
| Total Accounts Payable | -16.62% | 23.11% | 83.42% | 74.88% | 26.05% |
| Total Accrued Expenses | 199.53% | 147.34% | 75.38% | 99.96% | 18.10% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 158.75% | 570.76% | 970.49% | 2,316.85% | 1,006.92% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 121.06% | 172.27% | 118.19% | 200.90% | 47.81% |
|
|
|||||
| Total Current Liabilities | 121.06% | 172.27% | 118.19% | 200.90% | 47.81% |
| Long-Term Debt | 22.17% | 123.71% | 127.76% | 113.68% | 113.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -83.14% | -69.10% | -57.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 18.56% | 43.33% | 39.33% | 29.33% | 29.33% |
| Total Liabilities | 29.86% | 125.37% | 123.57% | 115.62% | 103.07% |
|
|
|||||
| Common Stock & APIC | 17.93% | 20.46% | 5.55% | 27.91% | 31.22% |
| Retained Earnings | -36.00% | -39.98% | -36.87% | -32.24% | -27.73% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -248.52% | -952.79% | -1,428.57% | -64.65% | 2.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -248.52% | -952.79% | -1,428.57% | -64.65% | 2.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -248.52% | -952.79% | -1,428.57% | -64.65% | 2.75% |
|
|
|||||
